Work

P-182 Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer

Year: 2023

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.04.238

Authors: R. Álvarez Gallego, R. Pazo Cid, B. López de San Vicente, T. Macarulla, E. Martinez de Castro, F. Garicano Goldaraz, M. Granja, I. Ghanem, J. Martinez-Galán, P. Ribera Fernández, R. Díaz Beveridge, J. Martín Valadés, C. Ángeles, A. Cubillo

Institutions: Hospital Universitario Miguel Servet, Hospital de Basurto, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, Hospital de Galdakao, Hospital Clínico San Carlos, Hospital Universitario La Paz, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Corporació Sanitària Parc Taulí, Hospital Universitari i Politècnic La Fe, MD Anderson Cancer Center Madrid, Hospital Universitari Sant Joan D'Alacant, HM Hospitales, Hospital Universitario HM Sanchinarro

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, Merck KGaA

OpenAlex ID: W4382807740

Cites:

Cited by:

Related to: 10